Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis
PolandStudy on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients
PolandStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
PolandStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
PolandStudy of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma
PolandStudy on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases
PolandStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
PolandStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandStudy of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis
PolandStudy of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years
PolandStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
